Skip to search formSkip to main contentSkip to account menu

injection site reaction

Known as: injection reactions site, REACTION INJECTION SITE (NOS), Reaction, Injection Site 
An intense reaction (usually immunologic) developing at the site of injection
National Institutes of Health

Related topics

Related topics

3 relations
Anesthesia, InfiltrationINJECTION SITE ABSCESS

Narrower (1)

injection site pain

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Differential Impact of Gonadotropin-releasing Hormone Antagonist Versus Agonist on Clinical Safety and Oncologic Outcomes on Patients with Metastatic Prostate Cancer: A Meta-analysis of Randomized…
Highly Cited
2019
Highly Cited
2019
Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial
Review
2014
Review
2014
Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
BACKGROUND Anti-tumor necrosis factor (TNF) agents are effective in treating patients with rheumatoid arthritis (RA), but they… 
Highly Cited
2014
Highly Cited
2014
A Randomized Phase III Trial of Melphalan and Dexamethasone (MDex) versus Bortezomib, Melphalan and Dexamethasone (BMDex) for Untreated Patients with AL Amyloidosis
Highly Cited
2013
Highly Cited
2013
Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial.
IMPORTANCE Small studies suggest that low-dose dopamine or low-dose nesiritide may enhance decongestion and preserve renal… 
Review
2012
Review
2012
Pantoprazole
SummaryAbstractPantoprazole (Protonix® ) is an irreversible proton pump inhibitor (PPI) that reduces gastric acid secretion.In… 
Highly Cited
2009
Highly Cited
2009
Australia's national Q fever vaccination program.
Review
2001
Review
2001
Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion protein.
OBJECTIVE To study injection site reactions (ISRs) associated with etanercept therapy. DESIGN Retrospective chart review, along… 
Review
2001
Review
2001
Dosing regimens and main adverse events of bisphosphonates.
Highly Cited
2000
Highly Cited
2000
Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor.
PURPOSE To evaluate granulocyte-macrophage colony-stimulating factor (GM-CSF) as surgical adjuvant therapy in patients with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)